
Pre-Surgical Immunotherapy Boosts Lung Cancer Survival: Findings from Global Trial Led by Irish Cancer Expert
A landmark advancement in lung cancer treatment has emerged from a recently published phase 3 clinical trial in the prestigious New England Journal of Medicine. The study reveals that incorporating the immunotherapy drug nivolumab in combination with …